We are proud to announce that the results of our first study on animal models are extremely positive. After a single dose, our five candidate DNA-based vaccines were able to induce a strong antibody response against the Covid-19 Spike protein in just 14 days. Vaccines were administered to animals through DNA-electroporation, which enhances vaccine uptake and recruit immune cells at the site of injection.
Such results in pre-clinical models demonstrate the immunogenicity of our candidate vaccines; two of them, in particular, induced the strongest antibody production. This makes us cautiously optimistic about the development of the best candidate for a future clinical study.
We are now looking for funding and collaborations in order to speed up the process in the next months.